StemTech Of Malaysia Automates Adult Stem-Cell Harvesting
This article was originally published in PharmAsia News
Executive Summary
Malaysia's StemTech International became the first biotech in Southeast Asia to establish an automated processing technology system for harvesting adult stem cells and cord blood. The company said it had obtained the U.S.-made FACSCAlibur Cytometer for higher stem-cell yield, allowing for a higher survival rate in transplantation. The cytometer is capable of producing CD34 cell analysis and testing for cell viability. (Click here for more